| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria, Liver | 89 | 2022 | 148 | 13.220 |
Why?
|
| Liver | 150 | 2023 | 1118 | 9.040 |
Why?
|
| Mitochondria | 63 | 2022 | 643 | 8.700 |
Why?
|
| Hepatocytes | 49 | 2022 | 205 | 7.650 |
Why?
|
| Reperfusion Injury | 66 | 2013 | 320 | 6.410 |
Why?
|
| Liver Transplantation | 76 | 2015 | 400 | 5.970 |
Why?
|
| Chemical and Drug Induced Liver Injury | 19 | 2022 | 131 | 3.760 |
Why?
|
| Animals | 352 | 2023 | 20877 | 3.710 |
Why?
|
| Calcium | 54 | 2022 | 929 | 3.690 |
Why?
|
| Adenosine Triphosphate | 46 | 2021 | 314 | 3.690 |
Why?
|
| Apoptosis | 48 | 2016 | 1640 | 3.550 |
Why?
|
| Rats | 231 | 2018 | 5300 | 3.450 |
Why?
|
| Acetaminophen | 19 | 2022 | 111 | 3.210 |
Why?
|
| Autophagy | 19 | 2022 | 207 | 3.180 |
Why?
|
| Kupffer Cells | 50 | 2004 | 75 | 3.160 |
Why?
|
| Reactive Oxygen Species | 33 | 2019 | 499 | 3.050 |
Why?
|
| Lysosomes | 14 | 2020 | 136 | 3.000 |
Why?
|
| Cyclosporine | 30 | 2015 | 121 | 2.960 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 22 | 2018 | 41 | 2.940 |
Why?
|
| Voltage-Dependent Anion Channels | 13 | 2019 | 40 | 2.900 |
Why?
|
| Necrosis | 35 | 2022 | 239 | 2.770 |
Why?
|
| Minocycline | 7 | 2023 | 61 | 2.770 |
Why?
|
| Ethanol | 31 | 2022 | 892 | 2.760 |
Why?
|
| Iron | 11 | 2022 | 197 | 2.650 |
Why?
|
| Oxidative Stress | 32 | 2022 | 718 | 2.570 |
Why?
|
| Microscopy, Confocal | 26 | 2018 | 337 | 2.480 |
Why?
|
| Fluorescent Dyes | 15 | 2022 | 191 | 2.450 |
Why?
|
| Cells, Cultured | 86 | 2022 | 2673 | 2.350 |
Why?
|
| Mitochondrial Membranes | 11 | 2019 | 45 | 2.090 |
Why?
|
| Permeability | 37 | 2015 | 131 | 2.060 |
Why?
|
| Iron Chelating Agents | 6 | 2022 | 31 | 1.990 |
Why?
|
| Rats, Sprague-Dawley | 77 | 2017 | 2083 | 1.960 |
Why?
|
| Oxygen Consumption | 34 | 2021 | 258 | 1.920 |
Why?
|
| Graft Survival | 42 | 2015 | 465 | 1.890 |
Why?
|
| Adenosine Diphosphate | 12 | 2021 | 66 | 1.810 |
Why?
|
| Intracellular Membranes | 25 | 2014 | 86 | 1.800 |
Why?
|
| Organ Preservation | 32 | 2006 | 69 | 1.800 |
Why?
|
| Glycolysis | 11 | 2021 | 79 | 1.730 |
Why?
|
| Energy Metabolism | 8 | 2021 | 222 | 1.700 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 10 | 2019 | 140 | 1.570 |
Why?
|
| Cell Survival | 54 | 2020 | 901 | 1.530 |
Why?
|
| Hypoxia | 27 | 2014 | 169 | 1.500 |
Why?
|
| Membrane Potential, Mitochondrial | 16 | 2019 | 93 | 1.490 |
Why?
|
| Cell Membrane Permeability | 13 | 2015 | 59 | 1.450 |
Why?
|
| Rhodamines | 11 | 2018 | 27 | 1.450 |
Why?
|
| Ion Channels | 9 | 2008 | 72 | 1.430 |
Why?
|
| Shock, Hemorrhagic | 5 | 2014 | 33 | 1.430 |
Why?
|
| Hydrogen-Ion Concentration | 40 | 2018 | 618 | 1.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 28 | 2006 | 626 | 1.340 |
Why?
|
| Mitochondrial Proteins | 9 | 2022 | 113 | 1.340 |
Why?
|
| Solutions | 24 | 2002 | 115 | 1.340 |
Why?
|
| Mice | 63 | 2023 | 8472 | 1.260 |
Why?
|
| Myocardial Reperfusion Injury | 12 | 2017 | 84 | 1.240 |
Why?
|
| Male | 142 | 2022 | 37281 | 1.240 |
Why?
|
| Liver Regeneration | 9 | 2012 | 38 | 1.230 |
Why?
|
| Alanine Transaminase | 19 | 2020 | 137 | 1.220 |
Why?
|
| Central Nervous System Depressants | 4 | 2018 | 182 | 1.200 |
Why?
|
| Cell Death | 32 | 2019 | 329 | 1.170 |
Why?
|
| Neoplasms | 7 | 2021 | 1660 | 1.150 |
Why?
|
| Ischemia | 9 | 2006 | 229 | 1.110 |
Why?
|
| Naphthols | 3 | 2018 | 5 | 1.100 |
Why?
|
| Mitochondria, Heart | 8 | 2012 | 53 | 1.100 |
Why?
|
| Oxygen | 23 | 2012 | 386 | 1.100 |
Why?
|
| Benzopyrans | 3 | 2018 | 21 | 1.080 |
Why?
|
| Tubulin | 4 | 2017 | 60 | 1.080 |
Why?
|
| Mice, Inbred C57BL | 31 | 2023 | 2790 | 1.080 |
Why?
|
| Tetracycline | 3 | 2014 | 29 | 1.050 |
Why?
|
| Signal Transduction | 20 | 2018 | 2688 | 1.020 |
Why?
|
| Cell Hypoxia | 20 | 2018 | 92 | 1.000 |
Why?
|
| Fatty Liver | 13 | 2014 | 97 | 0.980 |
Why?
|
| Free Radicals | 17 | 2008 | 65 | 0.980 |
Why?
|
| Liver Diseases, Alcoholic | 5 | 2018 | 27 | 0.970 |
Why?
|
| Analgesics, Non-Narcotic | 8 | 2020 | 45 | 0.970 |
Why?
|
| Neoplasm Proteins | 3 | 2016 | 307 | 0.960 |
Why?
|
| Doxycycline | 2 | 2014 | 49 | 0.950 |
Why?
|
| Phenols | 8 | 2022 | 73 | 0.950 |
Why?
|
| Flavonoids | 7 | 2010 | 109 | 0.920 |
Why?
|
| Rats, Inbred Lew | 40 | 2012 | 150 | 0.910 |
Why?
|
| Resuscitation | 4 | 2014 | 77 | 0.900 |
Why?
|
| Myocardium | 13 | 2017 | 1204 | 0.880 |
Why?
|
| Glycine | 9 | 2004 | 89 | 0.870 |
Why?
|
| Organ Preservation Solutions | 18 | 2012 | 45 | 0.850 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 3 | 2015 | 11 | 0.790 |
Why?
|
| Liver Diseases | 9 | 2013 | 193 | 0.790 |
Why?
|
| Endothelium, Vascular | 11 | 2001 | 371 | 0.760 |
Why?
|
| Potassium Channels | 2 | 2018 | 55 | 0.720 |
Why?
|
| Kidney | 7 | 2015 | 945 | 0.710 |
Why?
|
| Deferoxamine | 5 | 2022 | 45 | 0.690 |
Why?
|
| Calcium Channels | 7 | 2013 | 59 | 0.670 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2018 | 5 | 0.670 |
Why?
|
| Uridine | 1 | 2018 | 8 | 0.670 |
Why?
|
| Graft Rejection | 10 | 2007 | 458 | 0.660 |
Why?
|
| Endotoxemia | 1 | 2018 | 27 | 0.660 |
Why?
|
| Caspase 3 | 15 | 2014 | 233 | 0.660 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2020 | 163 | 0.660 |
Why?
|
| Intravital Microscopy | 1 | 2018 | 1 | 0.640 |
Why?
|
| Cytoprotection | 4 | 2014 | 39 | 0.630 |
Why?
|
| Ischemic Preconditioning | 4 | 2008 | 31 | 0.630 |
Why?
|
| Myocardial Infarction | 3 | 2014 | 807 | 0.630 |
Why?
|
| Carrier Proteins | 12 | 2016 | 597 | 0.620 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2018 | 234 | 0.610 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2015 | 114 | 0.610 |
Why?
|
| Glutamic Acid | 2 | 2017 | 332 | 0.600 |
Why?
|
| Liver Circulation | 12 | 2006 | 40 | 0.600 |
Why?
|
| Rabbits | 13 | 2018 | 509 | 0.590 |
Why?
|
| Liver Neoplasms | 4 | 2020 | 334 | 0.590 |
Why?
|
| Hair Follicle | 1 | 2017 | 37 | 0.580 |
Why?
|
| Adenine Nucleotide Translocator 2 | 1 | 2016 | 3 | 0.580 |
Why?
|
| Adenine Nucleotide Translocator 3 | 1 | 2016 | 3 | 0.580 |
Why?
|
| Lipopolysaccharides | 8 | 2000 | 455 | 0.580 |
Why?
|
| Membrane Potentials | 19 | 2010 | 200 | 0.580 |
Why?
|
| Piperazines | 3 | 2017 | 206 | 0.580 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2011 | 93 | 0.570 |
Why?
|
| Oxidative Phosphorylation | 16 | 2015 | 54 | 0.550 |
Why?
|
| Humans | 75 | 2021 | 68525 | 0.550 |
Why?
|
| Nitric Oxide | 6 | 2006 | 382 | 0.540 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 3 | 2020 | 27 | 0.520 |
Why?
|
| Peroxides | 7 | 2007 | 23 | 0.510 |
Why?
|
| Urea | 2 | 2012 | 51 | 0.510 |
Why?
|
| Mice, Knockout | 14 | 2019 | 1692 | 0.510 |
Why?
|
| Acetaldehyde | 4 | 2022 | 18 | 0.500 |
Why?
|
| Multiple Organ Failure | 1 | 2014 | 36 | 0.500 |
Why?
|
| Anti-Bacterial Agents | 8 | 2023 | 1026 | 0.500 |
Why?
|
| Protective Agents | 1 | 2014 | 36 | 0.490 |
Why?
|
| Fluid Therapy | 1 | 2014 | 59 | 0.490 |
Why?
|
| Ventricular Remodeling | 2 | 2014 | 318 | 0.480 |
Why?
|
| Oxidation-Reduction | 14 | 2021 | 567 | 0.480 |
Why?
|
| Rats, Inbred Strains | 37 | 1994 | 532 | 0.470 |
Why?
|
| Adenosine | 20 | 2012 | 165 | 0.470 |
Why?
|
| Camellia sinensis | 2 | 2010 | 9 | 0.460 |
Why?
|
| Biological Transport | 5 | 2009 | 210 | 0.450 |
Why?
|
| Plant Extracts | 3 | 2010 | 122 | 0.450 |
Why?
|
| Fructose | 9 | 2004 | 51 | 0.450 |
Why?
|
| DNA, Mitochondrial | 6 | 2022 | 84 | 0.440 |
Why?
|
| Polyphenols | 7 | 2013 | 34 | 0.440 |
Why?
|
| Fluoresceins | 11 | 2011 | 31 | 0.430 |
Why?
|
| Reactive Nitrogen Species | 3 | 2012 | 32 | 0.430 |
Why?
|
| Endothelium | 14 | 2007 | 98 | 0.430 |
Why?
|
| Models, Biological | 18 | 2013 | 981 | 0.420 |
Why?
|
| Caspases | 12 | 2006 | 194 | 0.420 |
Why?
|
| Superoxides | 9 | 2010 | 70 | 0.420 |
Why?
|
| Myocardial Contraction | 3 | 1998 | 383 | 0.410 |
Why?
|
| Fatty Liver, Alcoholic | 3 | 2012 | 5 | 0.400 |
Why?
|
| Phagosomes | 5 | 2012 | 19 | 0.400 |
Why?
|
| Kinetics | 29 | 2008 | 1047 | 0.390 |
Why?
|
| Salicylates | 2 | 2003 | 22 | 0.390 |
Why?
|
| Mitochondrial Swelling | 5 | 2016 | 10 | 0.390 |
Why?
|
| Cyclophilins | 3 | 2010 | 6 | 0.390 |
Why?
|
| Periodicals as Topic | 2 | 2004 | 158 | 0.390 |
Why?
|
| Pentoxifylline | 4 | 1995 | 12 | 0.380 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2007 | 100 | 0.380 |
Why?
|
| Liver Cirrhosis | 6 | 2019 | 301 | 0.380 |
Why?
|
| Antioxidants | 12 | 2016 | 304 | 0.380 |
Why?
|
| Smad7 Protein | 1 | 2010 | 11 | 0.370 |
Why?
|
| Time Factors | 27 | 2014 | 4655 | 0.370 |
Why?
|
| Luminescent Measurements | 5 | 2008 | 58 | 0.370 |
Why?
|
| Macrolides | 4 | 2012 | 48 | 0.370 |
Why?
|
| Aldehydes | 8 | 2015 | 34 | 0.360 |
Why?
|
| tert-Butylhydroperoxide | 9 | 2005 | 14 | 0.360 |
Why?
|
| Fluorescence | 7 | 2022 | 104 | 0.360 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 2 | 2020 | 21 | 0.360 |
Why?
|
| Tyrosine | 4 | 2015 | 196 | 0.360 |
Why?
|
| Calcium Signaling | 2 | 2012 | 97 | 0.360 |
Why?
|
| Cell Line, Tumor | 10 | 2019 | 1849 | 0.360 |
Why?
|
| Alcoholism | 5 | 2017 | 1109 | 0.360 |
Why?
|
| Reye Syndrome | 5 | 2009 | 11 | 0.350 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2015 | 201 | 0.350 |
Why?
|
| Allopurinol | 17 | 2012 | 36 | 0.350 |
Why?
|
| Rats, Wistar | 10 | 2017 | 371 | 0.340 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 126 | 0.340 |
Why?
|
| Amines | 2 | 2009 | 98 | 0.340 |
Why?
|
| Ionophores | 4 | 2005 | 25 | 0.340 |
Why?
|
| Cell Membrane | 10 | 2010 | 523 | 0.340 |
Why?
|
| Subtraction Technique | 1 | 2008 | 12 | 0.340 |
Why?
|
| Cations | 2 | 2007 | 51 | 0.340 |
Why?
|
| Immunity, Innate | 2 | 2006 | 156 | 0.340 |
Why?
|
| Cyclic AMP | 4 | 2016 | 223 | 0.340 |
Why?
|
| Cytosol | 12 | 2005 | 123 | 0.340 |
Why?
|
| Enzyme Inhibitors | 8 | 2016 | 659 | 0.330 |
Why?
|
| Neutrophils | 4 | 2003 | 204 | 0.330 |
Why?
|
| Peroxynitrous Acid | 7 | 2022 | 55 | 0.330 |
Why?
|
| Transplants | 1 | 2008 | 28 | 0.330 |
Why?
|
| Myocytes, Cardiac | 3 | 2018 | 442 | 0.320 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2006 | 27 | 0.320 |
Why?
|
| Organ Size | 10 | 2012 | 242 | 0.320 |
Why?
|
| L-Lactate Dehydrogenase | 19 | 2010 | 67 | 0.320 |
Why?
|
| Receptors, Purinergic P1 | 2 | 2000 | 18 | 0.320 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 178 | 0.310 |
Why?
|
| Vasodilation | 2 | 2011 | 85 | 0.310 |
Why?
|
| Image Enhancement | 1 | 2008 | 143 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2004 | 250 | 0.310 |
Why?
|
| Glutathione | 21 | 2014 | 343 | 0.310 |
Why?
|
| Cytokines | 3 | 2018 | 866 | 0.310 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2007 | 45 | 0.310 |
Why?
|
| Endotoxins | 4 | 2000 | 76 | 0.310 |
Why?
|
| Lipid Peroxidation | 6 | 2022 | 94 | 0.310 |
Why?
|
| RNA, Messenger | 11 | 2015 | 1663 | 0.300 |
Why?
|
| Electron Transport Complex III | 2 | 2005 | 5 | 0.300 |
Why?
|
| Ion Channel Gating | 2 | 2010 | 42 | 0.300 |
Why?
|
| Membrane Glycoproteins | 3 | 2006 | 370 | 0.300 |
Why?
|
| Fluorescence Polarization | 1 | 2007 | 14 | 0.300 |
Why?
|
| Calcimycin | 4 | 2003 | 32 | 0.300 |
Why?
|
| NADP | 6 | 2013 | 39 | 0.300 |
Why?
|
| Cytochromes c | 7 | 2016 | 75 | 0.290 |
Why?
|
| NF-kappa B | 9 | 2014 | 432 | 0.290 |
Why?
|
| Cyclin D1 | 1 | 2006 | 37 | 0.290 |
Why?
|
| Acute-Phase Proteins | 1 | 2006 | 13 | 0.280 |
Why?
|
| Phagocytosis | 9 | 2000 | 65 | 0.280 |
Why?
|
| Free Radical Scavengers | 7 | 2004 | 112 | 0.280 |
Why?
|
| Receptors, GABA-A | 3 | 2016 | 89 | 0.280 |
Why?
|
| Morphine | 1 | 2006 | 76 | 0.280 |
Why?
|
| fas Receptor | 5 | 2006 | 54 | 0.280 |
Why?
|
| Hepatitis | 1 | 2006 | 25 | 0.280 |
Why?
|
| Catechin | 4 | 2004 | 26 | 0.280 |
Why?
|
| Cations, Divalent | 3 | 2022 | 27 | 0.280 |
Why?
|
| NAD | 11 | 2018 | 73 | 0.280 |
Why?
|
| Electrophysiology | 8 | 2007 | 160 | 0.280 |
Why?
|
| NADPH Oxidases | 2 | 2003 | 80 | 0.280 |
Why?
|
| Immunosuppressive Agents | 6 | 2011 | 514 | 0.280 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2005 | 4 | 0.270 |
Why?
|
| Glucokinase | 1 | 2005 | 6 | 0.270 |
Why?
|
| Enterocytes | 1 | 2005 | 7 | 0.270 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 102 | 0.270 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2017 | 1745 | 0.270 |
Why?
|
| Organelles | 1 | 2005 | 18 | 0.270 |
Why?
|
| Raffinose | 16 | 2012 | 28 | 0.270 |
Why?
|
| Gene Transfer Techniques | 5 | 2010 | 173 | 0.270 |
Why?
|
| Tissue Preservation | 9 | 1996 | 44 | 0.270 |
Why?
|
| Rhodamine 123 | 3 | 2022 | 13 | 0.260 |
Why?
|
| Enzyme Activation | 9 | 2020 | 791 | 0.260 |
Why?
|
| In Vitro Techniques | 17 | 2011 | 765 | 0.260 |
Why?
|
| Mice, Inbred C3H | 6 | 2010 | 134 | 0.260 |
Why?
|
| Adenine | 3 | 2010 | 46 | 0.260 |
Why?
|
| Immunohistochemistry | 9 | 2015 | 1174 | 0.250 |
Why?
|
| Cryopreservation | 4 | 2002 | 103 | 0.250 |
Why?
|
| Camellia | 1 | 2004 | 2 | 0.250 |
Why?
|
| Inflammation | 4 | 2012 | 1030 | 0.250 |
Why?
|
| Libraries, Medical | 1 | 2004 | 16 | 0.250 |
Why?
|
| Peptidoglycan | 2 | 1994 | 14 | 0.240 |
Why?
|
| Homeostasis | 3 | 2015 | 291 | 0.240 |
Why?
|
| Cold Temperature | 10 | 1997 | 90 | 0.240 |
Why?
|
| Alcohol Dehydrogenase | 5 | 2014 | 32 | 0.240 |
Why?
|
| Microscopy, Electron, Scanning | 11 | 2002 | 236 | 0.240 |
Why?
|
| Cation Transport Proteins | 2 | 2014 | 11 | 0.240 |
Why?
|
| Disease Models, Animal | 11 | 2019 | 2550 | 0.230 |
Why?
|
| Biological Assay | 2 | 2016 | 88 | 0.230 |
Why?
|
| Microscopy, Fluorescence | 12 | 2006 | 261 | 0.230 |
Why?
|
| Mitochondrial Diseases | 3 | 2011 | 24 | 0.230 |
Why?
|
| Acidosis | 4 | 1998 | 31 | 0.230 |
Why?
|
| Tea | 3 | 2013 | 23 | 0.230 |
Why?
|
| Ruthenium Red | 2 | 2000 | 5 | 0.230 |
Why?
|
| Social Change | 1 | 2003 | 11 | 0.230 |
Why?
|
| Xanthenes | 5 | 2000 | 18 | 0.230 |
Why?
|
| Femoral Fractures | 3 | 2000 | 45 | 0.230 |
Why?
|
| Glucose | 5 | 2018 | 307 | 0.220 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2014 | 71 | 0.220 |
Why?
|
| Hep G2 Cells | 4 | 2019 | 68 | 0.220 |
Why?
|
| Heat-Shock Proteins | 1 | 2003 | 69 | 0.220 |
Why?
|
| Oligomycins | 6 | 1994 | 7 | 0.220 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2018 | 200 | 0.220 |
Why?
|
| Publishing | 1 | 2004 | 89 | 0.220 |
Why?
|
| Oxyquinoline | 1 | 2022 | 6 | 0.220 |
Why?
|
| Nisoldipine | 8 | 1998 | 9 | 0.220 |
Why?
|
| Thapsigargin | 1 | 2022 | 18 | 0.220 |
Why?
|
| Phosphoproteins | 2 | 2003 | 202 | 0.220 |
Why?
|
| Dinoprostone | 4 | 2001 | 110 | 0.220 |
Why?
|
| Chemical and Drug Induced Liver Injury, Chronic | 1 | 2022 | 3 | 0.220 |
Why?
|
| Sirolimus | 2 | 2015 | 118 | 0.220 |
Why?
|
| Aspartate Aminotransferases | 11 | 2020 | 87 | 0.220 |
Why?
|
| Bile Ducts | 3 | 2019 | 59 | 0.210 |
Why?
|
| Temperature | 7 | 2000 | 340 | 0.210 |
Why?
|
| Apoptosis Inducing Factor | 3 | 2016 | 10 | 0.210 |
Why?
|
| Animals, Newborn | 7 | 1998 | 396 | 0.210 |
Why?
|
| Insulin | 16 | 2012 | 617 | 0.210 |
Why?
|
| Photochemotherapy | 2 | 2012 | 59 | 0.210 |
Why?
|
| Adamantane | 3 | 2012 | 40 | 0.200 |
Why?
|
| Mice, Inbred BALB C | 4 | 2018 | 532 | 0.200 |
Why?
|
| Trifluoperazine | 4 | 2003 | 5 | 0.200 |
Why?
|
| Isoquinolines | 3 | 2016 | 37 | 0.200 |
Why?
|
| Osteogenesis | 1 | 2023 | 152 | 0.200 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 4 | 1995 | 11 | 0.200 |
Why?
|
| Internet | 1 | 2004 | 390 | 0.200 |
Why?
|
| Fasting | 6 | 2010 | 75 | 0.200 |
Why?
|
| Drug Overdose | 2 | 2020 | 67 | 0.200 |
Why?
|
| Phosphorylation | 5 | 2014 | 1199 | 0.200 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 4 | 2018 | 51 | 0.190 |
Why?
|
| Cytoskeleton | 3 | 1998 | 84 | 0.190 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2000 | 21 | 0.190 |
Why?
|
| Lactates | 3 | 2017 | 29 | 0.190 |
Why?
|
| Macrophage Activation | 4 | 1995 | 75 | 0.190 |
Why?
|
| Spectrometry, Fluorescence | 4 | 1995 | 112 | 0.190 |
Why?
|
| Oligopeptides | 3 | 2016 | 152 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2004 | 310 | 0.190 |
Why?
|
| Green Fluorescent Proteins | 2 | 2011 | 200 | 0.190 |
Why?
|
| Acetylcysteine | 4 | 2015 | 296 | 0.190 |
Why?
|
| Proteomics | 2 | 2017 | 246 | 0.190 |
Why?
|
| Cholestasis | 3 | 2008 | 90 | 0.190 |
Why?
|
| Cyanides | 5 | 1994 | 14 | 0.190 |
Why?
|
| Sodium-Hydrogen Exchangers | 4 | 1996 | 43 | 0.180 |
Why?
|
| Macrophages | 2 | 2006 | 647 | 0.180 |
Why?
|
| Endocytosis | 2 | 1998 | 113 | 0.180 |
Why?
|
| Perfusion | 23 | 2005 | 131 | 0.180 |
Why?
|
| Bile | 6 | 2004 | 35 | 0.180 |
Why?
|
| Gadolinium | 9 | 2000 | 88 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 1032 | 0.170 |
Why?
|
| Myocardial Ischemia | 3 | 1996 | 172 | 0.170 |
Why?
|
| Lung Transplantation | 6 | 1997 | 88 | 0.170 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2019 | 62 | 0.170 |
Why?
|
| Palmitates | 4 | 2015 | 20 | 0.170 |
Why?
|
| Smad3 Protein | 2 | 2010 | 33 | 0.170 |
Why?
|
| Transcription, Genetic | 3 | 2004 | 562 | 0.170 |
Why?
|
| Pyridines | 5 | 2017 | 261 | 0.170 |
Why?
|
| Electron Transport Complex IV | 2 | 2009 | 33 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 148 | 0.170 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 1998 | 23 | 0.160 |
Why?
|
| Female | 59 | 2018 | 38015 | 0.160 |
Why?
|
| Injections, Intraperitoneal | 2 | 2015 | 89 | 0.160 |
Why?
|
| Macrophages, Peritoneal | 1 | 1998 | 67 | 0.160 |
Why?
|
| N-Methylaspartate | 4 | 2000 | 59 | 0.160 |
Why?
|
| DNA Fragmentation | 5 | 2011 | 85 | 0.160 |
Why?
|
| Thionucleotides | 2 | 2015 | 21 | 0.160 |
Why?
|
| Hepatic Veins | 2 | 2011 | 13 | 0.160 |
Why?
|
| Hepatectomy | 4 | 2011 | 58 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2019 | 215 | 0.160 |
Why?
|
| Phospholipases A | 6 | 1999 | 41 | 0.160 |
Why?
|
| Oxidants | 3 | 2006 | 48 | 0.150 |
Why?
|
| Viral Proteins | 1 | 1998 | 149 | 0.150 |
Why?
|
| Cell Count | 2 | 2017 | 248 | 0.150 |
Why?
|
| Cell Nucleus | 6 | 2006 | 305 | 0.150 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 189 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1998 | 214 | 0.150 |
Why?
|
| Aniline Compounds | 4 | 2000 | 52 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2018 | 86 | 0.150 |
Why?
|
| Liposomes | 4 | 2015 | 107 | 0.150 |
Why?
|
| Cattle | 2 | 2017 | 475 | 0.150 |
Why?
|
| 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase | 1 | 2016 | 3 | 0.150 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2012 | 624 | 0.150 |
Why?
|
| DNA | 4 | 2007 | 597 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 137 | 0.150 |
Why?
|
| Melatonin | 1 | 2016 | 39 | 0.150 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2014 | 62 | 0.140 |
Why?
|
| Ruthenium Compounds | 1 | 2016 | 5 | 0.140 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2006 | 32 | 0.140 |
Why?
|
| Phospholipases | 2 | 1995 | 12 | 0.140 |
Why?
|
| Thermodynamics | 7 | 2000 | 162 | 0.140 |
Why?
|
| Starch | 1 | 2016 | 18 | 0.140 |
Why?
|
| Reperfusion | 6 | 2002 | 78 | 0.140 |
Why?
|
| Uncoupling Agents | 2 | 1990 | 10 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 4 | 2007 | 384 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2018 | 1034 | 0.140 |
Why?
|
| Transfection | 9 | 2007 | 782 | 0.140 |
Why?
|
| Pregnatrienes | 2 | 1993 | 3 | 0.140 |
Why?
|
| Fibroblasts | 3 | 2017 | 902 | 0.140 |
Why?
|
| Transplantation, Isogeneic | 7 | 2008 | 19 | 0.140 |
Why?
|
| Liver Failure | 1 | 1996 | 27 | 0.140 |
Why?
|
| Nocodazole | 2 | 2017 | 11 | 0.140 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2017 | 183 | 0.140 |
Why?
|
| Hypertonic Solutions | 8 | 1996 | 17 | 0.140 |
Why?
|
| Indoles | 2 | 2012 | 146 | 0.140 |
Why?
|
| Cytochrome c Group | 5 | 2003 | 22 | 0.140 |
Why?
|
| Aging | 2 | 2016 | 911 | 0.140 |
Why?
|
| Hydrogen Peroxide | 3 | 2006 | 168 | 0.130 |
Why?
|
| Nitric Oxide Synthase | 2 | 2010 | 163 | 0.130 |
Why?
|
| Protease Inhibitors | 4 | 2006 | 76 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2014 | 1173 | 0.130 |
Why?
|
| Luciferases | 5 | 1980 | 105 | 0.130 |
Why?
|
| beta-Galactosidase | 4 | 2010 | 88 | 0.130 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 1753 | 0.130 |
Why?
|
| Microcirculation | 7 | 2007 | 77 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 196 | 0.130 |
Why?
|
| Adenine Nucleotides | 6 | 1997 | 11 | 0.130 |
Why?
|
| Hair Cells, Auditory, Outer | 1 | 2015 | 33 | 0.130 |
Why?
|
| Bilirubin | 5 | 2012 | 51 | 0.130 |
Why?
|
| Superoxide Dismutase | 3 | 2006 | 149 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2019 | 617 | 0.130 |
Why?
|
| Stem Cells | 2 | 2007 | 248 | 0.130 |
Why?
|
| Lipid Metabolism | 4 | 2019 | 186 | 0.130 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2015 | 160 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2012 | 65 | 0.130 |
Why?
|
| Lung | 9 | 1997 | 849 | 0.130 |
Why?
|
| Acute Lung Injury | 1 | 2015 | 35 | 0.130 |
Why?
|
| Carbenoxolone | 1 | 2014 | 4 | 0.130 |
Why?
|
| Rotenone | 3 | 2010 | 10 | 0.130 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1994 | 22 | 0.130 |
Why?
|
| Creatinine | 2 | 2014 | 243 | 0.130 |
Why?
|
| Tissue Survival | 5 | 1998 | 22 | 0.130 |
Why?
|
| Peptides | 2 | 2016 | 455 | 0.130 |
Why?
|
| Indomethacin | 4 | 2000 | 107 | 0.130 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2015 | 46 | 0.120 |
Why?
|
| Cell Respiration | 3 | 2018 | 47 | 0.120 |
Why?
|
| Cell Compartmentation | 2 | 2009 | 41 | 0.120 |
Why?
|
| Colchicine | 2 | 2011 | 48 | 0.120 |
Why?
|
| Hyaluronic Acid | 2 | 2007 | 206 | 0.120 |
Why?
|
| Deoxycytidine | 1 | 2014 | 83 | 0.120 |
Why?
|
| Heart | 2 | 2000 | 850 | 0.120 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2014 | 39 | 0.120 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 839 | 0.120 |
Why?
|
| ADAM Proteins | 1 | 2014 | 53 | 0.120 |
Why?
|
| Liver Cirrhosis, Experimental | 2 | 2004 | 20 | 0.120 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2014 | 46 | 0.120 |
Why?
|
| Brain | 6 | 2016 | 2175 | 0.120 |
Why?
|
| Interleukin-1 | 1 | 1994 | 86 | 0.120 |
Why?
|
| Lipid Bilayers | 3 | 2013 | 24 | 0.120 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1993 | 31 | 0.120 |
Why?
|
| Blotting, Western | 4 | 2011 | 954 | 0.120 |
Why?
|
| Connexin 43 | 1 | 2014 | 62 | 0.120 |
Why?
|
| Liver Function Tests | 5 | 2012 | 114 | 0.120 |
Why?
|
| Mitochondrial Turnover | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cell Separation | 2 | 2012 | 132 | 0.120 |
Why?
|
| Adenoviridae | 3 | 2010 | 295 | 0.120 |
Why?
|
| Ceramides | 2 | 2019 | 578 | 0.120 |
Why?
|
| Protoporphyrins | 2 | 2014 | 10 | 0.120 |
Why?
|
| Electron Spin Resonance Spectroscopy | 4 | 2004 | 28 | 0.120 |
Why?
|
| Arthritis | 1 | 1993 | 53 | 0.120 |
Why?
|
| Mathematics | 9 | 1986 | 83 | 0.110 |
Why?
|
| Catalase | 2 | 2012 | 85 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 175 | 0.110 |
Why?
|
| Tacrolimus | 2 | 2022 | 127 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 222 | 0.110 |
Why?
|
| Amiloride | 4 | 1995 | 22 | 0.110 |
Why?
|
| Adenosine Triphosphatases | 3 | 1988 | 83 | 0.110 |
Why?
|
| Suramin | 1 | 2012 | 9 | 0.110 |
Why?
|
| Transcription Factors | 3 | 2015 | 753 | 0.110 |
Why?
|
| Phytotherapy | 2 | 2010 | 53 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2003 | 230 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2010 | 55 | 0.110 |
Why?
|
| Cathepsin B | 1 | 2012 | 33 | 0.110 |
Why?
|
| Sodium | 2 | 2005 | 161 | 0.110 |
Why?
|
| Death | 4 | 2015 | 38 | 0.110 |
Why?
|
| Hemodynamics | 2 | 2014 | 705 | 0.110 |
Why?
|
| Biomarkers | 3 | 2014 | 1593 | 0.110 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2012 | 11 | 0.110 |
Why?
|
| Enzyme Activators | 1 | 2012 | 14 | 0.110 |
Why?
|
| Amino Acid Sequence | 5 | 2016 | 1082 | 0.110 |
Why?
|
| Photosensitizing Agents | 1 | 2012 | 32 | 0.100 |
Why?
|
| Potassium Cyanide | 4 | 1993 | 8 | 0.100 |
Why?
|
| Nitrendipine | 4 | 1993 | 8 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2014 | 431 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 146 | 0.100 |
Why?
|
| Trypan Blue | 7 | 2007 | 24 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2011 | 7 | 0.100 |
Why?
|
| Pulmonary Veins | 1 | 2011 | 56 | 0.100 |
Why?
|
| Escherichia coli | 4 | 2000 | 368 | 0.100 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2011 | 22 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2010 | 111 | 0.100 |
Why?
|
| Cyclic CMP | 1 | 2010 | 2 | 0.100 |
Why?
|
| Propidium | 3 | 1997 | 26 | 0.100 |
Why?
|
| Uncoupling Protein 2 | 2 | 2008 | 18 | 0.100 |
Why?
|
| Trialkyltin Compounds | 2 | 1988 | 3 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 57 | 0.100 |
Why?
|
| Monensin | 4 | 2005 | 8 | 0.100 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2011 | 71 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 332 | 0.100 |
Why?
|
| Drug Synergism | 3 | 2004 | 260 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 64 | 0.100 |
Why?
|
| Microscopy | 2 | 1991 | 64 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2010 | 376 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2012 | 238 | 0.100 |
Why?
|
| Muscles | 1 | 1991 | 158 | 0.100 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2011 | 74 | 0.090 |
Why?
|
| Proteins | 5 | 2012 | 473 | 0.090 |
Why?
|
| Microtubules | 1 | 2010 | 104 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2010 | 99 | 0.090 |
Why?
|
| Endothelin-1 | 1 | 2011 | 122 | 0.090 |
Why?
|
| Mercuric Chloride | 1 | 1990 | 3 | 0.090 |
Why?
|
| Paclitaxel | 1 | 2010 | 140 | 0.090 |
Why?
|
| Lac Operon | 1 | 2010 | 54 | 0.090 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 75 | 0.090 |
Why?
|
| Cerebral Cortex | 3 | 1998 | 415 | 0.090 |
Why?
|
| Smad2 Protein | 1 | 2010 | 42 | 0.090 |
Why?
|
| Calcium Chloride | 2 | 2005 | 38 | 0.090 |
Why?
|
| Benzodioxoles | 2 | 2020 | 30 | 0.090 |
Why?
|
| Portal System | 2 | 2006 | 5 | 0.090 |
Why?
|
| Diptera | 3 | 1979 | 9 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 97 | 0.090 |
Why?
|
| Molecular Sequence Data | 6 | 2003 | 1446 | 0.090 |
Why?
|
| Neurons | 4 | 2000 | 881 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2007 | 689 | 0.090 |
Why?
|
| Protein Binding | 3 | 2011 | 1027 | 0.090 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2000 | 11 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2006 | 330 | 0.090 |
Why?
|
| Digitonin | 1 | 2008 | 5 | 0.090 |
Why?
|
| Blood Transfusion | 1 | 2010 | 205 | 0.090 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2000 | 59 | 0.080 |
Why?
|
| Ligands | 2 | 2015 | 317 | 0.080 |
Why?
|
| Hydroxybenzoates | 1 | 2008 | 9 | 0.080 |
Why?
|
| Anthracenes | 3 | 2019 | 26 | 0.080 |
Why?
|
| Xanthines | 4 | 1995 | 17 | 0.080 |
Why?
|
| Equipment Design | 2 | 2008 | 500 | 0.080 |
Why?
|
| Iron Overload | 1 | 2008 | 28 | 0.080 |
Why?
|
| Protein Transport | 2 | 2019 | 280 | 0.080 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2008 | 17 | 0.080 |
Why?
|
| Calcium Channel Blockers | 3 | 1998 | 137 | 0.080 |
Why?
|
| Metalloporphyrins | 1 | 2008 | 25 | 0.080 |
Why?
|
| Benzamides | 2 | 2020 | 156 | 0.080 |
Why?
|
| Premedication | 1 | 2008 | 49 | 0.080 |
Why?
|
| Leukocytes | 5 | 2012 | 99 | 0.080 |
Why?
|
| Heme Oxygenase-1 | 1 | 2008 | 40 | 0.080 |
Why?
|
| Kidney Diseases | 2 | 2013 | 307 | 0.080 |
Why?
|
| Magnesium | 3 | 2002 | 110 | 0.080 |
Why?
|
| Random Allocation | 2 | 2008 | 442 | 0.080 |
Why?
|
| Amino Acids | 3 | 1999 | 131 | 0.080 |
Why?
|
| Iodoacetates | 4 | 1992 | 6 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 121 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2014 | 362 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 1293 | 0.080 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 148 | 0.080 |
Why?
|
| Postmortem Changes | 3 | 1997 | 15 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 756 | 0.080 |
Why?
|
| Extracellular Space | 3 | 1998 | 121 | 0.080 |
Why?
|
| Methods | 6 | 1998 | 156 | 0.080 |
Why?
|
| Indicators and Reagents | 2 | 2000 | 63 | 0.080 |
Why?
|
| Polylysine | 2 | 2007 | 13 | 0.080 |
Why?
|
| Computer-Aided Design | 1 | 2008 | 101 | 0.080 |
Why?
|
| Cytochalasin B | 2 | 1998 | 7 | 0.080 |
Why?
|
| Base Sequence | 6 | 2018 | 1015 | 0.080 |
Why?
|
| Optics and Photonics | 1 | 1988 | 29 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2012 | 3702 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 215 | 0.080 |
Why?
|
| Phantoms, Imaging | 1 | 2008 | 189 | 0.080 |
Why?
|
| Glucagon | 2 | 2006 | 22 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 2077 | 0.080 |
Why?
|
| Hyperbilirubinemia | 1 | 2007 | 12 | 0.080 |
Why?
|
| Inflammation Mediators | 2 | 2006 | 244 | 0.080 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 2006 | 1 | 0.080 |
Why?
|
| Antigens, Differentiation | 1 | 2007 | 49 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2008 | 308 | 0.070 |
Why?
|
| Hydroquinones | 1 | 2007 | 15 | 0.070 |
Why?
|
| Neutrophil Infiltration | 1 | 2006 | 35 | 0.070 |
Why?
|
| Potassium Channel Blockers | 1 | 2006 | 32 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2012 | 561 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 1 | 2006 | 8 | 0.070 |
Why?
|
| Nitric Oxide Donors | 2 | 2004 | 54 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 166 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2011 | 546 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2017 | 397 | 0.070 |
Why?
|
| Receptors, Opioid | 1 | 2006 | 60 | 0.070 |
Why?
|
| Dextrans | 1 | 2006 | 33 | 0.070 |
Why?
|
| Sphingosine | 3 | 2012 | 315 | 0.070 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2006 | 9 | 0.070 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2006 | 63 | 0.070 |
Why?
|
| Electric Stimulation | 2 | 1997 | 218 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2004 | 181 | 0.070 |
Why?
|
| Alprostadil | 3 | 1996 | 20 | 0.070 |
Why?
|
| Androstadienes | 1 | 2006 | 41 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2004 | 230 | 0.070 |
Why?
|
| Arsenicals | 1 | 2005 | 8 | 0.070 |
Why?
|
| Prodrugs | 1 | 2006 | 54 | 0.070 |
Why?
|
| Endonucleases | 1 | 2005 | 10 | 0.070 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 50 | 0.070 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2006 | 65 | 0.070 |
Why?
|
| Muscle Contraction | 2 | 2000 | 210 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2006 | 99 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2006 | 87 | 0.070 |
Why?
|
| Anaerobiosis | 3 | 1997 | 44 | 0.070 |
Why?
|
| Cell Line | 5 | 2007 | 1752 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 272 | 0.070 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2005 | 67 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 1995 | 251 | 0.070 |
Why?
|
| Intracellular Fluid | 2 | 1996 | 24 | 0.070 |
Why?
|
| Glycosides | 2 | 2022 | 14 | 0.070 |
Why?
|
| Electron Transport | 7 | 2007 | 37 | 0.070 |
Why?
|
| Protein Kinase C | 2 | 1998 | 270 | 0.060 |
Why?
|
| Lipid Peroxides | 3 | 1995 | 19 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2005 | 191 | 0.060 |
Why?
|
| Pyrazolones | 1 | 2004 | 2 | 0.060 |
Why?
|
| Iodoacetic Acid | 4 | 1992 | 6 | 0.060 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cell Size | 2 | 1994 | 76 | 0.060 |
Why?
|
| Cytochromes c1 | 1 | 1984 | 1 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2004 | 25 | 0.060 |
Why?
|
| Drug Combinations | 2 | 2022 | 304 | 0.060 |
Why?
|
| DNA Damage | 1 | 2005 | 190 | 0.060 |
Why?
|
| Microscopy, Electron | 3 | 2002 | 351 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2004 | 99 | 0.060 |
Why?
|
| Viral Core Proteins | 1 | 2004 | 12 | 0.060 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2004 | 16 | 0.060 |
Why?
|
| Heart Arrest | 4 | 1997 | 113 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2015 | 254 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 123 | 0.060 |
Why?
|
| Calcineurin | 1 | 2003 | 13 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 37 | 0.060 |
Why?
|
| Gliotoxin | 1 | 2003 | 2 | 0.060 |
Why?
|
| Ligation | 2 | 2019 | 83 | 0.060 |
Why?
|
| Cadaver | 4 | 1996 | 136 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2004 | 193 | 0.060 |
Why?
|
| Transplantation, Homologous | 5 | 1997 | 242 | 0.060 |
Why?
|
| Sodium Cyanide | 2 | 1994 | 3 | 0.060 |
Why?
|
| Game Theory | 1 | 2003 | 7 | 0.060 |
Why?
|
| Hepacivirus | 1 | 2004 | 90 | 0.060 |
Why?
|
| Deoxyglucose | 2 | 1994 | 32 | 0.060 |
Why?
|
| Chloride Channels | 1 | 2003 | 22 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 48 | 0.060 |
Why?
|
| Caspase Inhibitors | 1 | 2003 | 36 | 0.060 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 19 | 0.060 |
Why?
|
| Bibliometrics | 1 | 2003 | 25 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 331 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 63 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2003 | 144 | 0.060 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2022 | 10 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2003 | 220 | 0.050 |
Why?
|
| Membranes | 3 | 1978 | 26 | 0.050 |
Why?
|
| Renal Circulation | 1 | 2002 | 49 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2003 | 152 | 0.050 |
Why?
|
| Polymers | 3 | 2007 | 244 | 0.050 |
Why?
|
| Disulfiram | 1 | 2022 | 22 | 0.050 |
Why?
|
| Xenobiotics | 1 | 2002 | 17 | 0.050 |
Why?
|
| Xanthine Oxidase | 3 | 1997 | 15 | 0.050 |
Why?
|
| Egtazic Acid | 3 | 1999 | 29 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2002 | 81 | 0.050 |
Why?
|
| Dietary Fats | 3 | 1998 | 103 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2002 | 87 | 0.050 |
Why?
|
| Protein Folding | 1 | 2002 | 82 | 0.050 |
Why?
|
| Binding Sites | 1 | 2003 | 631 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 89 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2022 | 122 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2002 | 81 | 0.050 |
Why?
|
| Penicillamine | 1 | 2001 | 10 | 0.050 |
Why?
|
| Albuminuria | 1 | 2002 | 171 | 0.050 |
Why?
|
| Tromethamine | 2 | 2005 | 4 | 0.050 |
Why?
|
| Gene Expression | 3 | 2012 | 770 | 0.050 |
Why?
|
| Hepatic Artery | 2 | 2008 | 25 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 110 | 0.050 |
Why?
|
| Proton-Motive Force | 1 | 2000 | 1 | 0.050 |
Why?
|
| Ferrous Compounds | 1 | 2000 | 18 | 0.050 |
Why?
|
| Diet | 2 | 2013 | 513 | 0.050 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2000 | 7 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2000 | 65 | 0.050 |
Why?
|
| Light | 2 | 2012 | 152 | 0.050 |
Why?
|
| Ferritins | 1 | 2020 | 49 | 0.050 |
Why?
|
| Esters | 1 | 2000 | 22 | 0.050 |
Why?
|
| Ion Transport | 1 | 2000 | 26 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2012 | 73 | 0.050 |
Why?
|
| Lysophospholipids | 2 | 2012 | 209 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 700 | 0.050 |
Why?
|
| Amidohydrolases | 1 | 2000 | 60 | 0.050 |
Why?
|
| Benzofurans | 2 | 1990 | 21 | 0.050 |
Why?
|
| Subcellular Fractions | 3 | 2010 | 92 | 0.050 |
Why?
|
| Proton-Translocating ATPases | 3 | 2000 | 9 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 114 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2011 | 22 | 0.050 |
Why?
|
| Eating | 1 | 2000 | 119 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 1999 | 124 | 0.050 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2000 | 49 | 0.040 |
Why?
|
| Phenylephrine | 2 | 1991 | 61 | 0.040 |
Why?
|
| Thiourea | 2 | 1996 | 16 | 0.040 |
Why?
|
| Vasopressins | 2 | 1991 | 33 | 0.040 |
Why?
|
| Artifacts | 1 | 2000 | 125 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 41 | 0.040 |
Why?
|
| Liver Glycogen | 3 | 2000 | 10 | 0.040 |
Why?
|
| Cytological Techniques | 1 | 1999 | 23 | 0.040 |
Why?
|
| Caspase 8 | 3 | 2007 | 40 | 0.040 |
Why?
|
| Computer Simulation | 2 | 2016 | 705 | 0.040 |
Why?
|
| Hypercapnia | 2 | 1998 | 17 | 0.040 |
Why?
|
| Ultraviolet Rays | 2 | 1999 | 130 | 0.040 |
Why?
|
| Denervation | 1 | 1999 | 23 | 0.040 |
Why?
|
| Papillary Muscles | 2 | 1996 | 30 | 0.040 |
Why?
|
| Succinate Dehydrogenase | 2 | 2017 | 13 | 0.040 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 1998 | 7 | 0.040 |
Why?
|
| Ribonucleotide Reductases | 1 | 2018 | 9 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 710 | 0.040 |
Why?
|
| Cadaverine | 1 | 1998 | 1 | 0.040 |
Why?
|
| Rifabutin | 1 | 1998 | 5 | 0.040 |
Why?
|
| Fura-2 | 4 | 1992 | 21 | 0.040 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1998 | 11 | 0.040 |
Why?
|
| Lactams, Macrocyclic | 1 | 1998 | 7 | 0.040 |
Why?
|
| Staurosporine | 1 | 1998 | 19 | 0.040 |
Why?
|
| Phospholipases A2 | 5 | 1997 | 32 | 0.040 |
Why?
|
| Stimulation, Chemical | 1 | 1998 | 57 | 0.040 |
Why?
|
| Quinones | 1 | 1998 | 13 | 0.040 |
Why?
|
| Benzoquinones | 1 | 1998 | 13 | 0.040 |
Why?
|
| Hydrogen | 1 | 1998 | 35 | 0.040 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1998 | 6 | 0.040 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1998 | 3 | 0.040 |
Why?
|
| Endosomes | 1 | 1998 | 45 | 0.040 |
Why?
|
| Carbon | 4 | 1992 | 122 | 0.040 |
Why?
|
| Models, Animal | 3 | 2008 | 252 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1998 | 165 | 0.040 |
Why?
|
| Isoproterenol | 1 | 1998 | 163 | 0.040 |
Why?
|
| Syndrome | 1 | 2018 | 255 | 0.040 |
Why?
|
| Type C Phospholipases | 1 | 1998 | 67 | 0.040 |
Why?
|
| Dactinomycin | 2 | 1996 | 31 | 0.040 |
Why?
|
| Salicylic Acid | 1 | 1997 | 4 | 0.040 |
Why?
|
| Water-Electrolyte Balance | 1 | 1978 | 43 | 0.040 |
Why?
|
| Aerobiosis | 1 | 1997 | 19 | 0.040 |
Why?
|
| Recombinant Proteins | 4 | 2004 | 742 | 0.040 |
Why?
|
| I-kappa B Proteins | 3 | 2004 | 47 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2004 | 1615 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2017 | 32 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1998 | 195 | 0.040 |
Why?
|
| Sepsis | 1 | 2000 | 233 | 0.040 |
Why?
|
| Ventricular Function | 1 | 2017 | 93 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 111 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 1998 | 182 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 1996 | 181 | 0.040 |
Why?
|
| Chelating Agents | 2 | 2012 | 47 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 1997 | 16 | 0.040 |
Why?
|
| Molecular Imaging | 1 | 2017 | 45 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 852 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 48 | 0.040 |
Why?
|
| Nitrites | 2 | 2012 | 53 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2017 | 107 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2017 | 71 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 1999 | 166 | 0.040 |
Why?
|
| Brefeldin A | 1 | 1996 | 11 | 0.040 |
Why?
|
| Phospholipids | 4 | 2006 | 108 | 0.040 |
Why?
|
| Workflow | 1 | 2017 | 100 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 39 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 107 | 0.040 |
Why?
|
| Cyclopentanes | 1 | 1996 | 15 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1070 | 0.040 |
Why?
|
| Carboxylic Acids | 1 | 1996 | 24 | 0.040 |
Why?
|
| Serpins | 1 | 1998 | 205 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2017 | 116 | 0.040 |
Why?
|
| Hypoxanthines | 3 | 1995 | 6 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2017 | 178 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 2000 | 357 | 0.040 |
Why?
|
| Glycogen | 2 | 2001 | 27 | 0.040 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 1996 | 32 | 0.030 |
Why?
|
| Pyruvates | 2 | 1993 | 4 | 0.030 |
Why?
|
| Pyruvic Acid | 2 | 1993 | 9 | 0.030 |
Why?
|
| Tissue Donors | 2 | 1995 | 195 | 0.030 |
Why?
|
| Osmolar Concentration | 4 | 2004 | 134 | 0.030 |
Why?
|
| Valproic Acid | 1 | 1996 | 93 | 0.030 |
Why?
|
| Genes | 1 | 1995 | 86 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1996 | 43 | 0.030 |
Why?
|
| Mitochondrial Dynamics | 1 | 2015 | 17 | 0.030 |
Why?
|
| Organelle Biogenesis | 1 | 2015 | 34 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 420 | 0.030 |
Why?
|
| Porosity | 1 | 2015 | 63 | 0.030 |
Why?
|
| Surface Properties | 2 | 2015 | 363 | 0.030 |
Why?
|
| Ions | 1 | 2015 | 50 | 0.030 |
Why?
|
| Lactic Acid | 2 | 1993 | 86 | 0.030 |
Why?
|
| Fractures, Closed | 1 | 1994 | 6 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 1996 | 133 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1995 | 65 | 0.030 |
Why?
|
| Aspirin | 1 | 1996 | 295 | 0.030 |
Why?
|
| Hydroxyethyl Starch Derivatives | 2 | 1994 | 24 | 0.030 |
Why?
|
| Static Electricity | 1 | 2015 | 91 | 0.030 |
Why?
|
| Sucrose | 2 | 2005 | 58 | 0.030 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 1995 | 157 | 0.030 |
Why?
|
| Alcohol Oxidoreductases | 3 | 1984 | 31 | 0.030 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2006 | 41 | 0.030 |
Why?
|
| Bucladesine | 1 | 1994 | 8 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1994 | 50 | 0.030 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2014 | 17 | 0.030 |
Why?
|
| ADAM17 Protein | 1 | 2014 | 28 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 3 | 1983 | 35 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 384 | 0.030 |
Why?
|
| Polymyxin B | 1 | 1994 | 5 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2014 | 30 | 0.030 |
Why?
|
| Biophysical Phenomena | 1 | 1994 | 25 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 1994 | 20 | 0.030 |
Why?
|
| Biophysics | 1 | 1994 | 41 | 0.030 |
Why?
|
| Intestines | 1 | 1995 | 114 | 0.030 |
Why?
|
| Cysteine | 1 | 2014 | 112 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 1996 | 157 | 0.030 |
Why?
|
| Triazoles | 1 | 1994 | 43 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 79 | 0.030 |
Why?
|
| Hepatitis, Animal | 1 | 1993 | 2 | 0.030 |
Why?
|
| Cell Wall | 1 | 1993 | 21 | 0.030 |
Why?
|
| Quinazolines | 1 | 1994 | 70 | 0.030 |
Why?
|
| Phosphates | 3 | 1981 | 72 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2006 | 311 | 0.030 |
Why?
|
| Tissue and Organ Procurement | 1 | 1996 | 164 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 294 | 0.030 |
Why?
|
| Vitamin K | 2 | 1991 | 14 | 0.030 |
Why?
|
| Guanidines | 1 | 1993 | 32 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2014 | 141 | 0.030 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2013 | 13 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 2 | 2003 | 61 | 0.030 |
Why?
|
| Sulfones | 1 | 1993 | 45 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2013 | 20 | 0.030 |
Why?
|
| Sodium Azide | 1 | 1993 | 4 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2013 | 47 | 0.030 |
Why?
|
| Methacrylates | 1 | 1993 | 31 | 0.030 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 1993 | 69 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 1213 | 0.030 |
Why?
|
| Cell Adhesion | 4 | 1997 | 324 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 114 | 0.030 |
Why?
|
| Azides | 1 | 1993 | 56 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 194 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1995 | 648 | 0.030 |
Why?
|
| Ketones | 1 | 2012 | 24 | 0.030 |
Why?
|
| Thiazoles | 1 | 1993 | 95 | 0.030 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 2 | 2003 | 22 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2015 | 232 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2014 | 239 | 0.030 |
Why?
|
| Age Factors | 2 | 2006 | 1860 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2013 | 411 | 0.030 |
Why?
|
| Amidines | 1 | 2012 | 7 | 0.030 |
Why?
|
| EGF Family of Proteins | 1 | 2012 | 17 | 0.030 |
Why?
|
| Cell Division | 2 | 2004 | 541 | 0.030 |
Why?
|
| Amphiregulin | 1 | 2012 | 19 | 0.030 |
Why?
|
| Benzylamines | 1 | 2012 | 28 | 0.030 |
Why?
|
| Nitrates | 1 | 2012 | 61 | 0.030 |
Why?
|
| Video Recording | 2 | 1990 | 145 | 0.030 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2012 | 3 | 0.030 |
Why?
|
| Isoindoles | 1 | 2012 | 9 | 0.030 |
Why?
|
| Dipeptides | 1 | 2012 | 89 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 218 | 0.030 |
Why?
|
| Thrombin | 1 | 1992 | 117 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 219 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 56 | 0.030 |
Why?
|
| Portal Vein | 2 | 2008 | 46 | 0.030 |
Why?
|
| Arginine Vasopressin | 1 | 1991 | 16 | 0.030 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 1971 | 5 | 0.030 |
Why?
|
| Inositol Phosphates | 1 | 1991 | 28 | 0.030 |
Why?
|
| Hepatopulmonary Syndrome | 1 | 2011 | 10 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 1993 | 168 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 2331 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1991 | 104 | 0.030 |
Why?
|
| Chemokines | 1 | 2012 | 119 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 73 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2011 | 1341 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 114 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2011 | 58 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 209 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 1991 | 82 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1993 | 507 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2006 | 381 | 0.030 |
Why?
|
| Collagen | 2 | 2008 | 636 | 0.030 |
Why?
|
| Coronary Disease | 1 | 1993 | 358 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2012 | 118 | 0.020 |
Why?
|
| Glutathione Disulfide | 1 | 2011 | 31 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 199 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 1991 | 36 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 946 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2013 | 601 | 0.020 |
Why?
|
| Electroretinography | 1 | 2011 | 122 | 0.020 |
Why?
|
| Electrolytes | 1 | 1990 | 47 | 0.020 |
Why?
|
| Caspase 9 | 2 | 2001 | 31 | 0.020 |
Why?
|
| Recurrence | 1 | 1993 | 948 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2013 | 586 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 298 | 0.020 |
Why?
|
| Malondialdehyde | 3 | 1997 | 43 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2011 | 141 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 1990 | 29 | 0.020 |
Why?
|
| Cystamine | 1 | 1990 | 2 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 1990 | 21 | 0.020 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2010 | 3 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2010 | 118 | 0.020 |
Why?
|
| Oxidoreductases | 2 | 1981 | 117 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 74 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 682 | 0.020 |
Why?
|
| Hypotonic Solutions | 1 | 1989 | 4 | 0.020 |
Why?
|
| Arachidonic Acid | 3 | 1997 | 86 | 0.020 |
Why?
|
| Muscle, Smooth | 2 | 2003 | 117 | 0.020 |
Why?
|
| Buffers | 1 | 1989 | 31 | 0.020 |
Why?
|
| Hydrolysis | 2 | 1991 | 144 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 434 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1989 | 196 | 0.020 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1989 | 4 | 0.020 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1989 | 5 | 0.020 |
Why?
|
| Gluconates | 1 | 1989 | 5 | 0.020 |
Why?
|
| Propylthiouracil | 3 | 1984 | 8 | 0.020 |
Why?
|
| Bicarbonates | 1 | 1989 | 21 | 0.020 |
Why?
|
| Chlorides | 1 | 1989 | 68 | 0.020 |
Why?
|
| Uncoupling Protein 3 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Triglycerides | 2 | 1999 | 184 | 0.020 |
Why?
|
| Nutritional Status | 1 | 1989 | 112 | 0.020 |
Why?
|
| Firefly Luciferin | 2 | 1979 | 5 | 0.020 |
Why?
|
| Nucleotides | 2 | 1982 | 29 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 1988 | 115 | 0.020 |
Why?
|
| Hypoxanthine | 3 | 1995 | 8 | 0.020 |
Why?
|
| Xanthine | 3 | 1995 | 14 | 0.020 |
Why?
|
| Risk Factors | 1 | 1998 | 5719 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2007 | 10 | 0.020 |
Why?
|
| DNA-Formamidopyrimidine Glycosylase | 1 | 2007 | 2 | 0.020 |
Why?
|
| Ionomycin | 1 | 1987 | 24 | 0.020 |
Why?
|
| Ethers | 1 | 1987 | 13 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 44 | 0.020 |
Why?
|
| Olive Oil | 1 | 2006 | 3 | 0.020 |
Why?
|
| Electrons | 1 | 1987 | 25 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2007 | 219 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2006 | 1447 | 0.020 |
Why?
|
| Plant Oils | 1 | 2006 | 31 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2006 | 13 | 0.020 |
Why?
|
| Glycerol | 1 | 2006 | 26 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1987 | 95 | 0.020 |
Why?
|
| Fibrosis | 1 | 2008 | 371 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 258 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1999 | 492 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 71 | 0.020 |
Why?
|
| Histocytochemistry | 3 | 1994 | 149 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2006 | 222 | 0.020 |
Why?
|
| Diuretics, Osmotic | 1 | 2005 | 5 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 2006 | 166 | 0.020 |
Why?
|
| Mannitol | 1 | 2005 | 25 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2006 | 274 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 179 | 0.020 |
Why?
|
| Ubiquinone | 2 | 1982 | 14 | 0.020 |
Why?
|
| Organ Specificity | 2 | 1996 | 167 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2006 | 133 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2006 | 128 | 0.020 |
Why?
|
| Edema | 1 | 2005 | 66 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 201 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2006 | 172 | 0.020 |
Why?
|
| Spleen | 1 | 2006 | 301 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2007 | 291 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 1999 | 1039 | 0.020 |
Why?
|
| Acetoacetates | 1 | 1984 | 2 | 0.020 |
Why?
|
| Body Weight | 2 | 1998 | 554 | 0.020 |
Why?
|
| Dogs | 2 | 1996 | 490 | 0.020 |
Why?
|
| Succinic Acid | 1 | 1984 | 9 | 0.020 |
Why?
|
| Succinates | 1 | 1984 | 9 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2264 | 0.020 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2004 | 5 | 0.020 |
Why?
|
| Cardioplegic Solutions | 2 | 1996 | 15 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2004 | 36 | 0.020 |
Why?
|
| Respiration, Artificial | 2 | 1996 | 190 | 0.020 |
Why?
|
| Acute Disease | 1 | 2006 | 658 | 0.020 |
Why?
|
| Xylitol | 1 | 1983 | 3 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2004 | 20 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 64 | 0.020 |
Why?
|
| Cytochalasins | 1 | 1983 | 1 | 0.010 |
Why?
|
| Phalloidine | 1 | 1983 | 5 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 1983 | 10 | 0.010 |
Why?
|
| Cytochromes | 2 | 1980 | 5 | 0.010 |
Why?
|
| Middle Aged | 2 | 2012 | 21119 | 0.010 |
Why?
|
| Drug Interactions | 2 | 1996 | 289 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 16 | 0.010 |
Why?
|
| Electrodes | 1 | 1984 | 147 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2003 | 63 | 0.010 |
Why?
|
| Exocytosis | 1 | 1983 | 34 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 100 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 189 | 0.010 |
Why?
|
| Dopamine Antagonists | 1 | 2003 | 65 | 0.010 |
Why?
|
| Triethyltin Compounds | 1 | 1983 | 1 | 0.010 |
Why?
|
| Vascular Resistance | 2 | 1996 | 179 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2003 | 191 | 0.010 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 2 | 1993 | 10 | 0.010 |
Why?
|
| Isotonic Solutions | 2 | 1994 | 25 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 2002 | 7 | 0.010 |
Why?
|
| Peroxidase | 1 | 2002 | 40 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1983 | 155 | 0.010 |
Why?
|
| Potassium | 2 | 1993 | 168 | 0.010 |
Why?
|
| Actins | 1 | 2003 | 249 | 0.010 |
Why?
|
| Software | 1 | 1984 | 418 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 60 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1981 | 168 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2001 | 67 | 0.010 |
Why?
|
| Adult | 3 | 2012 | 21375 | 0.010 |
Why?
|
| Cecum | 1 | 2000 | 39 | 0.010 |
Why?
|
| Dictyostelium | 1 | 2000 | 7 | 0.010 |
Why?
|
| Antimycin A | 1 | 1980 | 2 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 2000 | 12 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2000 | 120 | 0.010 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 1980 | 14 | 0.010 |
Why?
|
| Arabidopsis | 1 | 2000 | 20 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2000 | 67 | 0.010 |
Why?
|
| Ceramidases | 1 | 2000 | 47 | 0.010 |
Why?
|
| Leupeptins | 1 | 2000 | 23 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2000 | 165 | 0.010 |
Why?
|
| Antibodies | 1 | 2001 | 241 | 0.010 |
Why?
|
| Taurocholic Acid | 1 | 1999 | 2 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 282 | 0.010 |
Why?
|
| Anion Transport Proteins | 1 | 1999 | 6 | 0.010 |
Why?
|
| Growth Substances | 1 | 1999 | 77 | 0.010 |
Why?
|
| Culture Media | 1 | 1999 | 155 | 0.010 |
Why?
|
| Aminoquinolines | 1 | 1999 | 14 | 0.010 |
Why?
|
| CHO Cells | 1 | 1999 | 161 | 0.010 |
Why?
|
| Atractyloside | 1 | 1979 | 1 | 0.010 |
Why?
|
| Cricetinae | 1 | 1999 | 262 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2000 | 103 | 0.010 |
Why?
|
| Biolistics | 1 | 1999 | 5 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1999 | 49 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1999 | 93 | 0.010 |
Why?
|
| Valine | 1 | 1999 | 43 | 0.010 |
Why?
|
| Ammonium Chloride | 1 | 1998 | 4 | 0.010 |
Why?
|
| Microsurgery | 1 | 1999 | 46 | 0.010 |
Why?
|
| Lysine | 1 | 1999 | 96 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1998 | 78 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1999 | 334 | 0.010 |
Why?
|
| Gap Junctions | 1 | 1998 | 29 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1997 | 79 | 0.010 |
Why?
|
| Alanine | 1 | 1997 | 38 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 1996 | 9 | 0.010 |
Why?
|
| Feedback | 1 | 1977 | 90 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1997 | 104 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1996 | 147 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1997 | 102 | 0.010 |
Why?
|
| Extravascular Lung Water | 1 | 1996 | 5 | 0.010 |
Why?
|
| Fetus | 1 | 1996 | 157 | 0.010 |
Why?
|
| LIM Domain Proteins | 1 | 1995 | 15 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1996 | 133 | 0.010 |
Why?
|
| Gene Library | 1 | 1995 | 68 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 95 | 0.010 |
Why?
|
| DNA Primers | 1 | 1996 | 302 | 0.010 |
Why?
|
| Reference Values | 1 | 1996 | 579 | 0.010 |
Why?
|
| 1-Naphthylisothiocyanate | 1 | 1994 | 1 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 1994 | 1 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 546 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 208 | 0.010 |
Why?
|
| Anesthetics, Inhalation | 1 | 1994 | 21 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1994 | 20 | 0.010 |
Why?
|
| Nitrogen | 1 | 1994 | 57 | 0.010 |
Why?
|
| Cell Communication | 1 | 1994 | 116 | 0.010 |
Why?
|
| Astrocytes | 1 | 1996 | 270 | 0.010 |
Why?
|
| Coleoptera | 1 | 1973 | 8 | 0.010 |
Why?
|
| Transaminases | 1 | 1994 | 21 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1996 | 652 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 7028 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1998 | 738 | 0.010 |
Why?
|
| Contrast Media | 1 | 1996 | 594 | 0.010 |
Why?
|
| Isoflurophate | 1 | 1992 | 9 | 0.010 |
Why?
|
| Umbelliferones | 2 | 1983 | 2 | 0.010 |
Why?
|
| 7-Alkoxycoumarin O-Dealkylase | 2 | 1983 | 2 | 0.010 |
Why?
|
| Coumarins | 2 | 1983 | 7 | 0.010 |
Why?
|
| Oxygenases | 2 | 1983 | 8 | 0.010 |
Why?
|
| Aged | 1 | 1988 | 14842 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1971 | 25 | 0.010 |
Why?
|
| Hexoses | 1 | 1971 | 5 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1996 | 595 | 0.010 |
Why?
|
| Succinate Cytochrome c Oxidoreductase | 2 | 1982 | 2 | 0.010 |
Why?
|
| 1-Propanol | 1 | 1991 | 4 | 0.010 |
Why?
|
| Propanols | 1 | 1991 | 2 | 0.010 |
Why?
|
| Scattering, Radiation | 1 | 1971 | 30 | 0.010 |
Why?
|
| Television | 1 | 1991 | 28 | 0.010 |
Why?
|
| Gelatin | 1 | 1991 | 14 | 0.010 |
Why?
|
| Pressure | 1 | 1992 | 252 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1991 | 123 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1991 | 79 | 0.010 |
Why?
|
| Arachidonic Acids | 1 | 1991 | 97 | 0.010 |
Why?
|
| Nucleotides, Cyclic | 1 | 1990 | 5 | 0.010 |
Why?
|
| Hemoglobins | 2 | 1981 | 120 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1997 | 3256 | 0.010 |
Why?
|
| Colloids | 1 | 1990 | 43 | 0.010 |
Why?
|
| Uric Acid | 1 | 1989 | 37 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1993 | 1737 | 0.010 |
Why?
|
| Cell Movement | 1 | 1991 | 630 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 1987 | 20 | 0.000 |
Why?
|
| Survival Rate | 1 | 1990 | 1055 | 0.000 |
Why?
|
| Sorbitol | 1 | 1983 | 3 | 0.000 |
Why?
|
| Partial Pressure | 1 | 1982 | 19 | 0.000 |
Why?
|
| Diffusion | 1 | 1982 | 90 | 0.000 |
Why?
|
| Fluorometry | 1 | 1981 | 7 | 0.000 |
Why?
|
| Pyrazoles | 1 | 1982 | 190 | 0.000 |
Why?
|
| Dithionite | 1 | 1980 | 1 | 0.000 |
Why?
|
| Freeze Fracturing | 1 | 1980 | 11 | 0.000 |
Why?
|
| Ink | 1 | 1980 | 8 | 0.000 |
Why?
|
| Membrane Lipids | 1 | 1980 | 31 | 0.000 |
Why?
|
| Fiber Optic Technology | 1 | 1980 | 40 | 0.000 |
Why?
|
| Chemistry, Physical | 1 | 1980 | 21 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1980 | 62 | 0.000 |
Why?
|
| Cell-Free System | 1 | 1980 | 43 | 0.000 |
Why?
|
| Heme | 1 | 1980 | 17 | 0.000 |
Why?
|